|Day's Range||5.770 - 5.920|
|52 Week Range||4.220 - 6.400|
|PE Ratio (TTM)||21.06|
|Earnings Date||Mar 20, 2017 - Mar 23, 2017|
|Dividend & Yield||0.00 (0.00%)|
|1y Target Est||5.91|
FARMINGDALE, N.Y., March 7, 2017 /PRNewswire/ -- Misonix, Inc. (MSON), a provider of minimally invasive therapeutic ultrasonic medical devices that enhance clinical outcomes, today announced that it has entered into an exclusive distribution agreement with Shandong Weigao Orthopedic Device Company Limited ("Weigao Orthopedic"), a subsidiary of Shandong Weigao Group Medical Polymer Company Limited (1066.HK).Weigao Orthopedic is a medical device company in China specializing in research and development, production and sale of spine, trauma and joint orthopedic implants devices. Mr. Stavros Vizirgianakis, President and Chief Executive Officer of Misonix, said, "We are pleased to enter into this distribution agreement with Weigao Orthopedic, one of the most highly regarded orthopedic and spine surgery device providers in the People's Republic of China.
Chen Jianhua, the bespectacled owner of a ski-glove factory in the coastal province of Shandong, wants to make the big jump that typifies China's industrial shift: from contract manufacturer to establishing ...
Shandong Weigao Group Medical Polymer Co. Ltd. relative valuation is now NEUTRAL. It was previously rated UNDERVALUED, and has a fundamental analysis score of 53.Our analysis is based on comparing Shandong Weigao Group Medical Polymer Co. Ltd. with the following peers – LifeTech Scientific Corporation, PW Medtech Group Ltd., Nanjing Sinolife United Co., Ltd. Class […] (Read more...) The post Shandong Weigao Group Medical Polymer Co. Ltd. : Fairly valued, but don’t skip the other factors appeared first on CapitalCube.